Michael J Soth

5PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapyCheminformatics and quantitative structure-activity relationshipsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Feb 18, 2026
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5‑Azaindole Core.

Joshua B Cox, Vinay Nair, Pijus Mandal

|Jul 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy.

Kang Le, Michael J Soth, Jason B Cross

|Jul 22, 2021
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.

Matthew M Hamilton, Faika Mseeh, Timothy J McAfoos

|Oct 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties.

Michael J Soth, Kang Le, Maria Emilia Di Francesco

Pageof 1

Frequent Collaborators

2 joint publications

Barbara Czako

2 joint publications

Kang Le

1 joint publications

Matthew M Hamilton

1 joint publications

Joshua B Cox